19-1221963-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000455.5(STK11):c.877G>T(p.Glu293*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. E293E) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000455.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- familial pancreatic carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Peutz-Jeghers syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Genomics England PanelApp, G2P
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| STK11 | NM_000455.5 | c.877G>T | p.Glu293* | stop_gained | Exon 7 of 10 | ENST00000326873.12 | NP_000446.1 | |
| STK11 | NM_001407255.1 | c.877G>T | p.Glu293* | stop_gained | Exon 7 of 9 | NP_001394184.1 | ||
| STK11 | NR_176325.1 | n.2144G>T | non_coding_transcript_exon_variant | Exon 8 of 11 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| STK11 | ENST00000326873.12 | c.877G>T | p.Glu293* | stop_gained | Exon 7 of 10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
| STK11 | ENST00000652231.1 | c.877G>T | p.Glu293* | stop_gained | Exon 7 of 9 | ENSP00000498804.1 | ||||
| STK11 | ENST00000585748.3 | c.505G>T | p.Glu169* | stop_gained | Exon 9 of 12 | 3 | ENSP00000477641.2 | |||
| STK11 | ENST00000593219.6 | n.*702G>T | non_coding_transcript_exon_variant | Exon 8 of 11 | 3 | ENSP00000466610.1 | ||||
| STK11 | ENST00000593219.6 | n.*702G>T | 3_prime_UTR_variant | Exon 8 of 11 | 3 | ENSP00000466610.1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1410818Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 697290
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not provided Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.E293* pathogenic mutation (also known as c.877G>T), located in coding exon 7 of the STK11 gene, results from a G to T substitution at nucleotide position 877. This changes the amino acid from a glutamic acid to a stop codon within coding exon 7. This variant was reported as a mosaic finding in an individual with Peutz-Jeghers syndrome and has been observed in at least one heterozygous individual with a personal and/or family history that is consistent with Peutz-Jeghers syndrome (Jelsig AM et al. Fam Cancer, 2021 Jan;20:55-59; Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Peutz-Jeghers syndrome Pathogenic:1
The following ACMG criteria was used: PVS1; PM2_SUP; PS4_SUP -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at